Publications in DiVA – Magnus Lindskog

  • Tsakonas, Georgios; Lewensohn, Rolf; Botling, Johan; Ortiz-Villalon, Cristian et al.

    An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer

    Part of European Journal of Cancer, p. 24-34, 2020.

    Open access
  • Elmstedt, Sixten; Mogensen, Hanna; Hallmans, Dan-Erik; Tavelin, Björn et al.

    Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care

    Part of Acta Oncologica, p. 432-438, 2019.

    Open access
  • Stenman, Maria; Staehler, Michael; Szabados, Bernadett; Sandström, Per et al.

    Metastatic papillary renal cell carcinoma in the era of targeted therapy: a retrospective study from three European academic centres

    Part of Acta Oncologica, p. 306-312, 2019.

    Open access
  • Redig, Josefine; Dalen, Johan; Harmenberg, Ulrika; Lindskog, Magnus et al.

    Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

    Part of Cancer Management and Research, p. 1289-1297, 2019.

    Open access
  • Stenman, Maria; Sinclair, G.; Paavola, P.; Wersall, P. et al.

    Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014

    Part of Radiotherapy and Oncology, p. 501-506, 2018.

  • Lindskog, Magnus; Wahlgren, Thomas; Sandin, Rickard; Kowalski, Jan et al.

    Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations

    Part of Urologic Oncology, 2017.

  • Lynoe, Niels; NattochDag, Sara; Lindskog, Magnus; Juth, Niklas

    Heed or disregard a cancer patient's critical blogging?: An experimental study of two different framing strategies

    Part of BMC Medical Ethics, 2016.

    Open access
  • Stenman, Maria; Nearchou, Andreas Demetrios; Sandström, Per; Lindskog, Magnus et al.

    Metastatic papillary renal cell carcinoma: A retrospective study from two large academic centers in Sweden

    Part of Journal of Clinical Oncology, 2016.

  • Lindskog, Magnus; Wahlgren, Thomas; Sandin, Rickard; Kowalski, Jan et al.

    Overall survival (OS) in Swedish RCC patients treated 2000-2012: Update of the RENCOMP study

    Part of Journal of Clinical Oncology, 2015.

  • Lindskog, Magnus; Karvestedt, Lars; Furst, Carl Johan

    Glycaemic control in end-of-life care: fundamental or futile?

    Part of Current Opinion in Supportive and Palliative Care, p. 378-382, 2014.

  • Stenman, Maria; Laurell, Anna; Lindskog, Magnus

    Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma

    Part of Medical Oncology, p. 841-, 2014.

  • Al Hashmi, S.; Sadeghi, B.; Hassan, Z.; Abedi-Valugerdi, M. et al.

    Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion

    Part of Bone Marrow Transplantation, p. 843-848, 2013.

  • Sörenson, S.; Fohlin, H.; Lindgren, A.; Lindskog, Magnus et al.

    Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy

    Part of European Journal of Cancer, p. 115-120, 2013.

  • Gleissman, Helena; Segerström, Lova; Hamberg, Mats; Ponthan, Frida et al.

    Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo

    Part of International Journal of Cancer, p. 1703-1711, 2011.

  • Johansson, Ann-Sofie; Norén-Nyström, Ulrika; Larefalk, Åsa; Holmberg, Dan et al.

    Fish oil delays lymphoma progression in the TLL mouse

    Part of Leukemia and Lymphoma, p. 2092-2097, 2010.

  • Felth, Jenny; Rickardson, Linda; Rosén, Josefin; Wickström, Malin et al.

    Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs

    Part of Journal of natural products (Print), p. 1969-1974, 2009.

  • Johansson, Ann-Sofie; Pawelzik, Sven-Christian; Larefalk, Åsa; Jakobsson, Per-Johan et al.

    Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide

    Part of Leukemia and Lymphoma, p. 1198-1203, 2009.